SELANDER ROBERT W 4
4 · HEALTHEQUITY, INC. · Filed Apr 11, 2025
Insider Transaction Report
Form 4
SELANDER ROBERT W
Director
Transactions
- Exercise/Conversion
Common Stock
2025-04-09$28.68/sh+12,500$358,500→ 90,719 total - Sale
Common Stock
2025-04-09$76.79/sh−2,067$158,718→ 88,652 total - Sale
Common Stock
2025-04-09$78.06/sh−3,283$256,270→ 85,369 total - Sale
Common Stock
2025-04-09$78.81/sh−400$31,524→ 84,969 total - Exercise/Conversion
Stock Option (right to buy)
2025-04-09−12,500→ 0 totalExercise: $28.68Exp: 2025-09-29→ Common Stock (12,500 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on July 09, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.42 to $77.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) and (3) of this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.59 to $78.53, inclusive.
- [F4]The option is immediately exercisable.